Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Choosing the right accounts—taxable, tax-advantaged, or retirement—can significantly reduce taxes on index fund gains and distributions.
25,988 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
The Supreme Court decision clears a path for roughly $180 billion in tariff refunds to importers, yet Goldman Sachs c...
A new science council linked to Trump signals a stronger link between AI and crypto policy. This morning minute exami...
In the race to dominate AI inference, two hardware contenders stand out: Nvidia and Cerebras. This guide breaks down ...
Guardian (GRDN) is shaping up as a data-driven growth story in 2026. This deep dive breaks down the Q1 2026 earnings ...
As mortgage rates shift and originations evolve, loandepot (LDI) 2025 earnings will hinge on rate flow, loan mix, and...
A new deal could amplify AMD's growth path by tying AI memory optimization to data-center demand. Learn why this acqu...
A new Bitcoin mining cost model, tested with Riot Platforms data, finds power costs can be covered only at a BTC pric...
Mission Produce stock is rocketing as traders weigh earnings, margins, and guidance. Learn what drives the move, how ...
Investors are weighing AMDs AI bets against its OpenAI ties and the broader AI spending boom. This guide breaks down ...
Explore how Invitation Homes navigated Q4 2025, the drivers behind its earnings, and what savvy investors should watc...
March is on the horizon, and I’m paying close attention to IBM as it heads into a new earnings cycle. The century-old...